Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-14

FDA Approved: NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE — Supplemental Application (Nordic Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE from Nordic Pharma, Inc., updating its approved labeling/ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neomycin sulfate, polymyxin B sulfate and dexamethasone (Neomycin sulfate, polymyxin B sulfate and dexamethasone)

Snippet

SUPPL AP for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE)